Additionally, the significance of AMPK in vascular function is well-supported by anti-atherosclerosis agents, including statins, thiazolidinediones, leptin and rosiglitazone, which exhibit anti-atherosclerosis effects, at least partially, through the activation of AMPK (Zou and Wu, 2008). The gene discussed is PRKAA2; the disease is atherosclerosis.